E09.3523 Drug/chem diab w prolif diab rtnop w trctn dtch macula, bi
Instructional Notes:
E09.3523 Description: Drug/chem diab w prolif diab rtnop w trctn dtch macula, bi ↓
E09.352 Description: Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula ↓
E09.35 Description: Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy ↓
E09.3 Description: Drug or chemical induced diabetes mellitus with ophthalmic complications ↓
E09 Description: Drug or chemical induced diabetes mellitus Exclude1:
diabetes mellitus due to underlying condition (E08.-)
gestational diabetes (O24.4-)
neonatal diabetes mellitus (P70.2)
postpancreatectomy diabetes mellitus (E13.-)
postprocedural diabetes mellitus (E13.-)
secondary diabetes mellitus NEC (E13.-)
type 1 diabetes mellitus (E10.-)
type 2 diabetes mellitus (E11.-)
Code First:
poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Use Additional Code:
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
E00-E89 Description: Endocrine, nutritional and metabolic diseases Exclude1:
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Notes:
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.